# Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

> **NCT01848327** · NA · COMPLETED · sponsor: **University of Miami** · enrollment: 124 (actual)

## Conditions studied

- Relapsing Remitting MS
- Secondary Progressive MS
- Primary Progressive MS

## Interventions

- **DIETARY_SUPPLEMENT:** Caprylic Triglyceride
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01848327
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2018-01-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01848327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01848327, "Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01848327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*